1. Schlant RC, Friesinger GC II, Leonard JJ. Clinical competence in exercise testing. A statement for physicians from the ACP/ACC/AHA Task Force on Clinical Privileges in Cardiology. J Am Coll Cardiol 1990;16:1061–1065.
2. Gibbons RJ, Balady GJ, Beasley JW, et al. ACC/AHA guidelines for exercise testing. A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (Committee on Exercise Testing). J Am Coll Cardiol 1997;30:260–311.
3. Gibbons RJ, Balady GJ, Bricker JT, et al. ACC/AHA 2002 guideline update for exercise testing: summary article. A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (Committee to update the 1997 exercise testing guidelines). J Am Coll Cardiol 2002;40:1531–1540.
4. Hendel RC, Jamil T, Glover DK. Pharmacologic stress testing: new methods and new agents. J Nucl Cardiol 2003;10:197–204.
5. Chaitman BR. Exercise stress testing, in Braunwald E (ed): Heart Disease: A Textbook of Cardiovascular Medicine. Philadelphia, WB Saunders Company, 1997, vol 1, ed 5, pp 153–174.
6. Wackers F, Soufer R, Zaret BL. Nuclera cardiology, in Braunwald E (ed): Heart Disease: A Textbook of Cardiovascular Medicine. Philadelphia, W B Saunders Company, 1997, ed 5, pp 273–308.
7. Ritchie JL, Bateman TM, Bonow RO, et al. Guidelines for clinical use of cardiac radionuclide imaging. Report of the American College of Cardiology/American Heart Association Task Force on assessment of diagnostic and therapeutic cardiovascular procedures (Committee on radionuclide imaging), developed in collaboration with the American Society of Nuclear Cardiology. J Am Coll Cardiol 1995;25:521–547.
8. Klocke FJ, Baird MG, Lorell BH, et al. ACC/AHA/ASNC guidelines for the clinical use of cardiac radionuclide imaging—executive summary: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (ACC/AHA/ASNC Committee to Revise the 1995 guidelines for the clinical use of cardiac radionuclide imaging). J Am Coll Cardiol 2003;42:1318–1333.
9. Diamond G, Forrester JS. Analysis of probability as an aid in the clinical diagnosis of coronary-artery disease. N Engl J Med 1979;300:1350–1358.
10. Mieres JH, Shaw LJ, Hendel RC, et al. American Society of Nuclear Cardiology consensus statement: task force on women and coronary artery disease—the role of myocardial perfusion imaging in the clinical evaluation of coronary artery disease in women [correction]. J Nucl Cardiol 2003;10:95–101.
11. Hlatky MA, Pryor DB, Harrell FE Jr, et al. Factors affecting sensitivity and specificity of exercise electrocardiography. Multivariable analysis. Am J Med 1984;77:64–71.
12. Kwok Y, Kim C, Grady D, et al. Meta-analysis of exercise testing to detect coronary artery disease in women. Am J Cardiol 1999;83:660–666.
13. Giri S, Shaw LJ, Murthy DR, et al. Impact of diabetes on the risk stratification using stress single-photon emission computed tomography myocardial perfusion imaging in patients with symptoms suggestive of coronary artery disease. Circulation 2002;105:32–40.
14. Fletcher GF, Balady G, Froelicher VF, et al. Exercise standards. A statement for healthcare professionals from the American Heart Association writing group. Circulation 1995;91:580–615.
15. Mark DB, Shaw L, Harrell FE Jr, et al. Prognostic value of a treadmill exercise score in outpatients with suspected coronary artery disease. N Engl J Med 1991;325:849–853.
16. Morise AP, Diamond GA. Comparison of the sensitivity and specificity of exercise electrocardiography in biased and unbiased populations of men and women. Am Heart J 1995;130:741–747.
17. Roitman D, Jones WB, Sheffield LT. Comparison of submaximal exercise ECG test with coronary cineangiocardiogram. Ann Intern Med 1970;72:641–647.
18. Verani M. Pharmacologic stress myocardial perfusion imaging. Curr Probl Cardiol 1993;18:481–528.
19. Detrano R, Janosi A, Lyons KP, et al. Factors affecting sensitivity and specificity of a diagnostic test: the exercise thallium scintigram. Am J Med 1988;84:699–710.
20. Santana-Boado C, Candell-Riera J, Castell-Conesa J, et al. Diagnostic accuracy of technetium-99m-MIBI myocardial SPECT in women and men. J Nucl Med 1998;39:751–755.
21. Goodgold HM, Rehder JG, Samuels LD, et al. Improved interpretation of exercise Tl-201 myocardial perfusion scintigraphy in women: characterization of breast attenuation artifacts. Radiology 1987;165:361–366.
22. Kong BA, Shaw L, Miller DD, et al. Comparison of accuracy for detecting coronary artery disease and side-effect profile of dipyridamole thallium-201 myocardial perfusion imaging in women versus men. Am J Cardiol 1992;70:168–173.
23. Leppo J. Dipyridamole-thallium imaging: the lazy man’s stress test. J Nuc Med 1989;30:281–287.
24. Gibbons RJ, Abrams J, Chatterjee K, et al. ACC/AHA 2002 guideline update for the management of patients with chronic stable angina—summary article: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (Committee on the management of patients with chronic stable angina). J Am Coll Cardiol 2003;41:159–168.
25. Geleijnse ML, Elhendy A, Fioretti PM, et al. Dobutamine stress myocardial perfusion imaging. J Am Coll Cardiol 2000;36:2017–2027.
26. Marchant E, Pichard AD, Casanegra P, et al. Effect of intravenous dipyridamole on regional coronary blood flow with 1-vessel coronary artery disease: evidence against coronary steal. Am J Cardiol 1984;53:718–721.
27. Feldman RL, Nichols WW, Pepine CJ, et al. Acute effect of intravenous dipyridamole on regional coronary hemodynamics and metabolism. Circulation 1981;64:333–344.
28. Wilson RF, Wyche K, Christensen BV, et al. Effects of adenosine on human coronary arterial circulation. Circulation 1990;82:1595–1606.
29. Abreu A, Mahmarian JJ, Nishimura S, et al. Tolerance and safety of pharmacologic coronary vasodilation with adenosine in association with thallium-201 scintigraphy in patients with suspected coronary artery disease. J Am Coll Cardiol 1991;18:730–735.
30. Elliot M, Holly T, Leonard S, et al. Impact of an abbreviated adenosine protocol incorporating adjunctive exercise on adverse effects and image quality in patients undergoing stress myocardial perfusion imaging. J Nucl Cardiol 2000;7:584–589.
31. Coma-Canella I. Dobutamine stress test to diagnose teh presence and severity of coronary artery lesions in angina. Eur Heart J 1991;12:1198–1204.
32. Elhendy A, Valkema R, Van Domburg R, et al. Safety of dobutamine-atropine stress myocardial perfusion scintigraphy. J Nucl Med 1998;39:1662–1666.
33. Armstrong WF, Zoghbi WA. Stress echocardiography: current methodology and clinical applications. J Am Coll Cardiol 2005;45:1739–1747.
34. Quinones MA, Verani MS, Haichin RM, et al. Exercise echocardiography versus 201Tl single-photon emission computed tomography in evaluation of coronary artery disease. Analysis of 292 patients. Circulation 1992;85:1026–1031.
35. Fleischmann KE, Hunink MG, Kuntz KM, et al. Exercise echocardiography or exercise SPECT imaging? A meta-analysis of diagnostic test performance. JAMA 1998;280:913–920.
36. Crouse LJ, Harbrecht JJ, Vacek JL, et al. Exercise echocardiography as a screening test for coronary artery disease and correlation with coronary arteriography. Am J Cardiol 1991;67:1213–1218.
37. Marwick TH, Torelli J, Harjai K, et al. Influence of left ventricular hypertrophy on detection of coronary artery disease using exercise echocardiography. J Am Coll Cardiol 1995;26:1180–1186.
38. Pearlman AS, Ryan T, Picard MH, et al. Evolving trends in the use of echocardiography: a study of Medicare beneficiaries. J Am Coll Cardiol 2007;49:2283–2291.
39. Eichenberger AC, Schuiki E, Kochli VD, et al. Ischemic heart disease: assessment with gadolinium-enhanced ultrafast MR imaging and dipyridamole stress. J Magn Reson Imaging 1994;4:425–431.
40. Lima JA, Desai MY. Cardiovascular magnetic resonance imaging: current and emerging applications. J Am Coll Cardiol 2004;44:1164–1171.
41. Zoghbi WA, Barasch E. Dobutamine MRI: a serious contender in pharmacological stress imaging? Circulation 1999;99:730–732.
42. Rijneke R, Ascoop C, Talmon J. Clinical significance of upsloping ST segments in exercise electrocardiography. Circulation 1980;61:671–678.
43. Weiner DA, Ryan TJ, McCabe CH, et al. Prognostic importance of a clinical profile and exercise test in medically treated patients with coronary artery disease. J Am Coll Cardiol 1984;3:772–779.
44. McNeer JF, Margolis JR, Lee KL, et al. The role of the exercise test in the evaluation of patients for ischemic heart disease. Circulation 1978;57:64–70.
45. Cole CR, Blackstone EH, Pashkow FJ, et al. Heart-rate recovery immediately after exercise as a predictor of mortality. N Engl J Med 1999;341:1351–1357.
46. McHam SA, Marwick TH, Pashkow FJ, et al. Delayed systolic blood pressure recovery after graded exercise: an independent correlate of angiographic coronary disease. J Am Coll Cardiol 1999;34:754–759.
47. Sketch M, Mooss A, Butler M, et al. Digoxin-induced positive exercise test: their clinical and prognostic significance. Am J Cardiol 1981;48:655–659.